Tag: JNJ

As worries emerge about the delta variant and the J&J shot, health officials — and, so far, the research — say the vaccinated are still protected

The delta variant is already the most dominant strain of the virus in some U.S. states, and that’s putting some Americans easing back into “normal” life on edge. This variant, which was first identified in India in December, now makes up nearly half of COVID-19 cases in some regions and one-quarter of cases in the […]

Read More

Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away

The “full” approval of Pfizer’s and Moderna’s COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration’s decision might not come until the end of the year. The Pfizer Inc. PFE, +0.43% and Moderna Inc. MRNA, -0.34% vaccines, along with Johnson & Johnson’s JNJ, +1.82% COVID-19 shot, […]

Read More